Trials / Completed
CompletedNCT06572397
Open-Label Study of Safety of H1337 in Healthy Volunteers
An Open-Label Study Assessing the Ocular and Systemic Safety and Systemic Absorption of H1337 Ophthalmic Solution, 1% in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- D. Western Therapeutics Institute, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The trial will evaluate the safety of one dose regimen of H-1337 \[1% twice daily (b.i.d.)\] in both eyes in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | H-1337 1.0% | ophthalmic solution |
Timeline
- Start date
- 2024-09-16
- Primary completion
- 2024-10-14
- Completion
- 2024-10-14
- First posted
- 2024-08-27
- Last updated
- 2025-02-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06572397. Inclusion in this directory is not an endorsement.